MPRO is an independent nonprofit and a national leader in healthcare quality improvement and medical review. MPRO also provides consultative services, medical and utilization review and data analysis to federal agencies, state Medicaid and public health agencies, healthcare facilities, private health plans and other third party payers.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

TAPPING EVOLUTION TO IMPROVE BIOTECH PRODUCTS

biotech | September 26, 2016

news image

Scientists can improve protein-based drugs by reaching into the evolutionary past, a paper published in Nature Biotechnology proposes. As a proof of concept for this approach, the research team from Emory, Children's Healthcare of Atlanta and Georgia Tech showed how "ancestral sequence reconstruction" or ASR can guide engineering of the blood clotting protein known as factor VIII, which is deficient in the inherited disorder hemophilia A....

Read More

PALL LIFE SCIENCES EXTENDS THE RANGE OF CONTINUOUS, SINGLE-USE TECHNOLOGIES TO IMPROVE SPEED AND QUALITY OF BIOPHARMACEUTICAL PRODUCTION

Pall Corporation | October 04, 2016

news image

Pall Corporation, a global leader in filtration, separation and purification, is pleased to announce the launch of breakthrough technologies that for the first time enable integrated, process-scale continuous production of biotherapies in single-use formats. Biopharmaceutical manufacturers are increasingly incorporating continuous technologies to replace traditional batch methods in order to improve consistency, reduce production footprints and shorten lead times. Single-use technologies further...

Read More

ETHIOPIA: IMPROVING AGRICULTURAL PRODUCTIVITY THROUGH BIOTECHNOLOGY

biotech | March 18, 2017

news image

Agriculture is the mainstay of our economy as 80 per cent of the population earns its living directly from it. It supplies food to local market and also serve as a means of hard currency earning. However, as a rain-fed one, it is highly vulnerable to extreme weather conditions such as drought and flood. Moreover, the prevalence of pests and herbs highly compromise the amount of yield....

Read More

A FUTURE GENE THERAPY COULD BE DELIVERED IN TINY ‘NANOCONTAINERS’

Labiotech.eu | January 28, 2020

news image

A Swiss research group has developed tiny plastic particles that could carry gene therapies to the center of the cell with less risk of getting attacked by the immune system than conventional gene therapies. The majority of gene therapies in use today are delivered to the DNA of target cells using viral vectors. While efficient at their job, viral vectors can risk triggering the immune system to destroy them. This can lead to the therapy becoming ineffective....

Read More
news image

TAPPING EVOLUTION TO IMPROVE BIOTECH PRODUCTS

biotech | September 26, 2016

Scientists can improve protein-based drugs by reaching into the evolutionary past, a paper published in Nature Biotechnology proposes. As a proof of concept for this approach, the research team from Emory, Children's Healthcare of Atlanta and Georgia Tech showed how "ancestral sequence reconstruction" or ASR can guide engineering of the blood clotting protein known as factor VIII, which is deficient in the inherited disorder hemophilia A....

Read More
news image

PALL LIFE SCIENCES EXTENDS THE RANGE OF CONTINUOUS, SINGLE-USE TECHNOLOGIES TO IMPROVE SPEED AND QUALITY OF BIOPHARMACEUTICAL PRODUCTION

Pall Corporation | October 04, 2016

Pall Corporation, a global leader in filtration, separation and purification, is pleased to announce the launch of breakthrough technologies that for the first time enable integrated, process-scale continuous production of biotherapies in single-use formats. Biopharmaceutical manufacturers are increasingly incorporating continuous technologies to replace traditional batch methods in order to improve consistency, reduce production footprints and shorten lead times. Single-use technologies further...

Read More
news image

ETHIOPIA: IMPROVING AGRICULTURAL PRODUCTIVITY THROUGH BIOTECHNOLOGY

biotech | March 18, 2017

Agriculture is the mainstay of our economy as 80 per cent of the population earns its living directly from it. It supplies food to local market and also serve as a means of hard currency earning. However, as a rain-fed one, it is highly vulnerable to extreme weather conditions such as drought and flood. Moreover, the prevalence of pests and herbs highly compromise the amount of yield....

Read More
news image

A FUTURE GENE THERAPY COULD BE DELIVERED IN TINY ‘NANOCONTAINERS’

Labiotech.eu | January 28, 2020

A Swiss research group has developed tiny plastic particles that could carry gene therapies to the center of the cell with less risk of getting attacked by the immune system than conventional gene therapies. The majority of gene therapies in use today are delivered to the DNA of target cells using viral vectors. While efficient at their job, viral vectors can risk triggering the immune system to destroy them. This can lead to the therapy becoming ineffective....

Read More